Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: MPO Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2α.

Authors: Meng, Qingtao; Wu, Shenshen; Wang, Yajie; Xu, Jin; Sun, Hao; Lu, Runze; Gao, Na; Yang, Hongbao; Li, Xiaobo; Tang, Boping; Aschner, Michael; Chen, Rui

Published In Cancer Res, (2018 May 15)

Abstract: Myeloperoxidase (MPO) promoter SNPs rs2243828 (-764T>C) and rs2333227 (G-463A) program malignant phenotypes by regulating MPO transcriptional activity. In this study, we enrolled a total of 1,175 controls and 1,078 patients with colorectal cancer with comprehensive clinical and survival information to assess whether these SNPs could affect the susceptibility and development of colorectal cancer. The MPO rs2333227 TT genotype significantly increased the risk of colorectal cancer and decreased the overall survival time of patients. Colorectal cancer cells with the rs2333227 TT genotype exhibited enhanced proliferation, migration, and invasion capacity in vitro and in vivo Mechanistically, we found that MPO SNP rs2333227 C to T mutation altered the binding affinity of the transcription factors AP-2α to the rs2333227 mutation region, sequentially enhancing expression levels of MPO and activating further IL23A-MMP9 axis-mediated oncogenic signaling. Taken together, our findings indicate that MPO SNP rs2333227 serves as a marker of enhanced risk for development of colorectal cancer.Significance: MPO polymorphisms are a guide for high risk and poor prognosis in patients colorectal cancer. Cancer Res; 78(10); 2760-9. ©2018 AACR.

PubMed ID: 29540402 Exiting the NIEHS site

MeSH Terms: Animals; Case-Control Studies; Cell Line, Tumor; Cell Movement/genetics; Cell Proliferation/genetics; China; Colorectal Neoplasms/genetics*; Colorectal Neoplasms/mortality; Colorectal Neoplasms/pathology; Female; Genetic Predisposition to Disease/genetics*; Humans; Interleukin-23 Subunit p19/metabolism; Male; Matrix Metalloproteinase 9/metabolism; Mice; Mice, Nude; Neoplasm Transplantation; Peroxidase/genetics*; Polymorphism, Single Nucleotide/genetics*; Prognosis; Promoter Regions, Genetic/genetics*; Protein Binding/genetics; Transcription Factor AP-2/genetics; Transcription Factor AP-2/metabolism; Transplantation, Heterologous

Back
to Top
Last Reviewed: October 07, 2024